Gastroparesis Drugs Market Report 2026
Download Free Sample Buy Now
Gastroparesis Drugs Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Gastroparesis Drugs Market Report 2026

Global Outlook – By Drug Type (Over-the-counter (OTC) Drugs, Prescription Drugs), By Drug Class (Prokinetic Agents, Antiemetic Drugs, Proton Pump Inhibitors, Other Drug Classes), By Disease Type (Diabetic Gastroparesis, Post-Surgical Gastroparesis, Idiopathic Gastroparesis, Other Disease Types), By Route Of Administration (Oral, Injectables, Other Routes Of Administration), By Distribution Channel (Hospitals, Pharmacies, Clinics, E-commerce) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Gastroparesis Drugs Market Overview

• Gastroparesis Drugs market size has reached to $5.7 billion in 2025

• Expected to grow to $7.37 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%

• Growth Driver: Increasing Prevalence Of Diabetes Fuels Growth In The Gastroparesis Drugs Market

• Market Trend: Advances In Novel Therapies Aim To Improve Stomach Motility And Relieve Digestive Symptoms

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gastroparesis Drugs Market?

Gastroparesis drugs are medications used to manage and treat gastroparesis, a condition where the stomach's ability to empty its contents is delayed, causing symptoms such as nausea, vomiting, and abdominal pain. These drugs typically include prokinetics to stimulate stomach motility, antiemetics to control nausea and vomiting, and medications to manage pain and other symptoms associated with the condition.

The main drug types of gastroparesis drugs are over-the-counter (OTC) drugs and prescription drugs. Over-the-counter (OTC) drugs are medications that can be purchased without a prescription from a healthcare professional. These drugs are used to treat various disease types, such as diabetic gastroparesis, post-surgical gastroparesis, idiopathic gastroparesis, and others, and are consumed through various routes of administration, mainly oral, injectable, and others. Several drug types include prokinetic agents, antiemetic drugs, proton pump inhibitors, others, which are sold through hospitals, pharmacies, clinics, and e-commerce distribution channels.

Gastroparesis Drugs Market Global Report 2026 Market Report bar graph

What Is The Gastroparesis Drugs Market Size and Share 2026?

The gastroparesis drugs market size has grown strongly in recent years. It will grow from $5.7 billion in 2025 to $6.02 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increasing diagnosis of diabetic gastroparesis, long-standing use of prokinetic and antiemetic drugs, growing prevalence of diabetes-related gastrointestinal disorders, availability of both otc and prescription symptom relief medications, expansion of gastroenterology care services.

What Is The Gastroparesis Drugs Market Growth Forecast?

The gastroparesis drugs market size is expected to see strong growth in the next few years. It will grow to $7.37 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to rising global diabetes prevalence, growing awareness of gastroparesis as a chronic condition, increasing demand for effective long-term symptom control, expansion of access to specialty gastrointestinal care, ongoing need for improved motility-enhancing therapies. Major trends in the forecast period include growing reliance on prokinetic agents for symptom management, increasing use of combination drug therapy for gastroparesis, rising demand for prescription-based gastroparesis treatments, expansion of symptom-focused treatment approaches, greater use of oral drug formulations for long-term management.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Gastroparesis Drugs Market Segmentation

1) By Drug Type: Over-the-counter (OTC) Drugs, Prescription Drugs

2) By Drug Class: Prokinetic Agents, Antiemetic Drugs, Proton Pump Inhibitors, Other Drug Classes

3) By Disease Type: Diabetic Gastroparesis, Post-Surgical Gastroparesis, Idiopathic Gastroparesis, Other Disease Types

4) By Route Of Administration: Oral, Injectables, Other Routes Of Administration

5) By Distribution Channel: Hospitals, Pharmacies, Clinics, E-commerce

Subsegments:

1) By Over-the-counter (OTC) Drugs: Antacids, Anti-Nausea Medications, Antiemetics, Digestive Enzyme Supplements

2) By Prescription Drugs: Prokinetic Agents, Antiemetic Drugs, Antibiotics, Antidepressants

What Is The Driver Of The Gastroparesis Drugs Market?

The increasing prevalence of diabetes is expected to propel the growth of the gastroparesis drugs market going forward. Diabetes is a chronic metabolic disorder characterized by elevated blood sugar levels resulting from insufficient insulin production or impaired insulin utilization. The prevalence of diabetes is rising due to sedentary lifestyles, unhealthy dietary behaviors, genetic predisposition, urbanization, aging populations, and growing obesity rates. The gastroparesis drugs market supports diabetes care by providing medications that relieve symptoms such as nausea, vomiting, and delayed gastric emptying common gastrointestinal complications associated with diabetic gastroparesis. For instance, in March 2024, according to the Office for Health Improvement & Disparities, a UK-based government department, between March 2022 and March 2023, individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, while type 2 diabetes patients saw a 21% increase, and the percentage achieving target HbA1c levels rose to 37.9%, the highest value ever reported by the National Diabetes Audit. Therefore, the increasing prevalence of diabetes is driving the growth of the gastroparesis drugs industry.

Key Players In The Global Gastroparesis Drugs Market

Major companies operating in the gastroparesis drugs market are Evoke Pharma Inc., Takeda Pharmaceutical Inc., AbbVie Inc., Salix Pharmaceuticals Inc., Pfizer Inc., Sanofi SA, AstraZeneca plc, Teva Pharmaceutical Inc., Bausch Health Companies Inc., Abbott Laboratories, GSK plc, Eisai Co. Ltd., Vanda Pharmaceuticals Inc., Theravance Biopharma Inc., ANI Pharmaceuticals Inc., Cadila Pharmaceuticals, Cipla Ltd., Ipca Laboratories Ltd., Neurogastrx Inc., Processa Pharmaceuticals Inc.

Global Gastroparesis Drugs Market Trends and Insights

Major companies operating in the gastroparesis drugs market are focusing on developing innovative solutions such as novel prokinetic therapies to improve gastric motility and reduce symptoms. Novel prokinetic therapies are new medications designed to stimulate and enhance the normal movement of the stomach and intestines to help food pass more effectively. For instance, in December 2023, Vanda Pharmaceuticals Inc., a US-based biopharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for the filing of Vanda's New Drug Application (NDA) for tradipitant for the treatment of symptoms of gastroparesis. This approval is for tradipitant, an investigational oral neurokinin-1 receptor antagonist, to treat gastroparesis, a serious digestive disorder with unmet medical needs. This acceptance marks a key regulatory milestone for Vanda as it continues to pursue marketing authorization for tradipitant in gastroparesis patients.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Gastroparesis Drugs Market?

In May 2025, Renexxion Ireland Ltd., an Ireland-based biopharmaceutical company, partnered with Dr. Falk Pharma GmbH to advance the global development of naronapride for the treatment of gastroparesis. This partnership aims to complete the global Phase 2b MOVE-IT study and accelerate the development of Naronapride as a potential best-in-class therapy for gastroparesis. Dr. Falk Pharma GmbH is a Germany-based company that specializes in digestive and metabolic medicine.

Regional Insights

North America was the largest region in the gastroparesis drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastroparesis Drugs Market?

The gastroparesis drugs market consists of sales of metoclopramide, ondansetron, amitriptyline, and erythromycin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastroparesis Drugs Market Report 2026?

The gastroparesis drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastroparesis drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Gastroparesis Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $6.02 billion
Revenue Forecast In 2035 $7.37 billion
Growth Rate CAGR of 5.7% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Drug Type, Drug Class, Disease Type, Route Of Administration, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Evoke Pharma Inc., Takeda Pharmaceutical Inc., AbbVie Inc., Salix Pharmaceuticals Inc., Pfizer Inc., Sanofi SA, AstraZeneca plc, Teva Pharmaceutical Inc., Bausch Health Companies Inc., Abbott Laboratories, GSK plc, Eisai Co. Ltd., Vanda Pharmaceuticals I
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gastroparesis Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gastroparesis Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gastroparesis Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gastroparesis Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growing Reliance On Prokinetic Agents For Symptom Management

4.2.2 Increasing Use Of Combination Drug Therapy For Gastroparesis

4.2.3 Rising Demand For Prescription-Based Gastroparesis Treatments

4.2.4 Expansion Of Symptom-Focused Treatment Approaches

4.2.5 Greater Use Of Oral Drug Formulations For Long-Term Management

5. Gastroparesis Drugs Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Pharmacies

5.4 Specialty Gastroenterology Centers

5.5 Home Care Settings

6. Gastroparesis Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gastroparesis Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gastroparesis Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gastroparesis Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gastroparesis Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gastroparesis Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gastroparesis Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gastroparesis Drugs Market Segmentation

9.1. Global Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Over-the-counter (OTC) Drugs, Prescription Drugs

9.2. Global Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prokinetic Agents, Antiemetic Drugs, Proton Pump Inhibitors, Other Drug Classes

9.3. Global Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diabetic Gastroparesis, Post-Surgical Gastroparesis, Idiopathic Gastroparesis, Other Disease Types

9.4. Global Gastroparesis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Injectables, Other Routes Of Administration

9.5. Global Gastroparesis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Pharmacies, Clinics, E-commerce

9.6. Global Gastroparesis Drugs Market, Sub-Segmentation Of Over-the-counter (OTC) Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antacids, Anti-Nausea Medications, Antiemetics, Digestive Enzyme Supplements

9.7. Global Gastroparesis Drugs Market, Sub-Segmentation Of Prescription Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prokinetic Agents, Antiemetic Drugs, Antibiotics, Antidepressants

10. Gastroparesis Drugs Market Regional And Country Analysis

10.1. Global Gastroparesis Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gastroparesis Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gastroparesis Drugs Market

11.1. Asia-Pacific Gastroparesis Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gastroparesis Drugs Market

12.1. China Gastroparesis Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gastroparesis Drugs Market

13.1. India Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gastroparesis Drugs Market

14.1. Japan Gastroparesis Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gastroparesis Drugs Market

15.1. Australia Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gastroparesis Drugs Market

16.1. Indonesia Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gastroparesis Drugs Market

17.1. South Korea Gastroparesis Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gastroparesis Drugs Market

18.1. Taiwan Gastroparesis Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gastroparesis Drugs Market

19.1. South East Asia Gastroparesis Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gastroparesis Drugs Market

20.1. Western Europe Gastroparesis Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gastroparesis Drugs Market

21.1. UK Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gastroparesis Drugs Market

22.1. Germany Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gastroparesis Drugs Market

23.1. France Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gastroparesis Drugs Market

24.1. Italy Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gastroparesis Drugs Market

25.1. Spain Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gastroparesis Drugs Market

26.1. Eastern Europe Gastroparesis Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gastroparesis Drugs Market

27.1. Russia Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gastroparesis Drugs Market

28.1. North America Gastroparesis Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gastroparesis Drugs Market

29.1. USA Gastroparesis Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gastroparesis Drugs Market

30.1. Canada Gastroparesis Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gastroparesis Drugs Market

31.1. South America Gastroparesis Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gastroparesis Drugs Market

32.1. Brazil Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gastroparesis Drugs Market

33.1. Middle East Gastroparesis Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gastroparesis Drugs Market

34.1. Africa Gastroparesis Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Gastroparesis Drugs Market, Segmentation By Drug Type, Segmentation By Drug Class, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gastroparesis Drugs Market Regulatory and Investment Landscape

36. Gastroparesis Drugs Market Competitive Landscape And Company Profiles

36.1. Gastroparesis Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gastroparesis Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gastroparesis Drugs Market Company Profiles

36.3.1. Evoke Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Takeda Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Salix Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Gastroparesis Drugs Market Other Major And Innovative Companies

Sanofi SA, AstraZeneca plc, Teva Pharmaceutical Inc., Bausch Health Companies Inc., Abbott Laboratories, GSK plc, Eisai Co. Ltd., Vanda Pharmaceuticals Inc., Theravance Biopharma Inc., ANI Pharmaceuticals Inc., Cadila Pharmaceuticals, Cipla Ltd., Ipca Laboratories Ltd., Neurogastrx Inc., Processa Pharmaceuticals Inc.

38. Global Gastroparesis Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gastroparesis Drugs Market

40. Gastroparesis Drugs Market High Potential Countries, Segments and Strategies

40.1 Gastroparesis Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Gastroparesis Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Gastroparesis Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Gastroparesis Drugs Market, Overview Of Key Products - Product Examples
  • Table 2: Global Gastroparesis Drugs Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Gastroparesis Drugs Market, Supply Chain Analysis
  • Table 4: Global Gastroparesis Drugs Market, Major Raw Material Providers
  • Table 5: Global Gastroparesis Drugs Market, Major Resource Providers
  • Table 6: Global Gastroparesis Drugs Market, Major Manufacturers (Suppliers)
  • Table 7: Global Gastroparesis Drugs Market, Major Distributors And Channel Partners
  • Table 8: Global Gastroparesis Drugs Market, Key Technologies & Future Trends
  • Table 9: Global Gastroparesis Drugs Market, Major Trends
  • Table 10: Global Gastroparesis Drugs Market, Major End Users
  • Table 11: Global Gastroparesis Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Gastroparesis Drugs Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Gastroparesis Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Gastroparesis Drugs Market - TAM, US$ Billion, 2025
  • Table 15: Global Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Gastroparesis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Gastroparesis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Gastroparesis Drugs Market, Sub-Segmentation Of Over-the-counter (OTC) Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Gastroparesis Drugs Market, Sub-Segmentation Of Prescription Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Gastroparesis Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Gastroparesis Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Gastroparesis Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Gastroparesis Drugs Market - Company Scoring Matrix
  • Table 98: Evoke Pharma Inc. Financial Performance
  • Table 99: Takeda Pharmaceutical Inc. Financial Performance
  • Table 100: AbbVie Inc. Financial Performance
  • Table 101: Salix Pharmaceuticals Inc. Financial Performance
  • Table 102: Pfizer Inc. Financial Performance
  • Table 103: Global Gastroparesis Drugs Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Gastroparesis Drugs Market, Competitive Dashboard
  • Table 105: Global Gastroparesis Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Gastroparesis Drugs Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030
  • Table 107: Global, Gastroparesis Drugs Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Table 108: Global, Gastroparesis Drugs Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030

List Of Figures

    Figure 1: Global Gastroparesis Drugs Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Gastroparesis Drugs Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Gastroparesis Drugs Market, Supply Chain Analysis
  • Figure 4: Global Gastroparesis Drugs Market, Major Raw Material Providers
  • Figure 5: Global Gastroparesis Drugs Market, Major Resource Providers
  • Figure 6: Global Gastroparesis Drugs Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Gastroparesis Drugs Market, Major Distributors And Channel Partners
  • Figure 8: Global Gastroparesis Drugs Market, Key Technologies & Future Trends
  • Figure 9: Global Gastroparesis Drugs Market, Major Trends
  • Figure 10: Global Gastroparesis Drugs Market, Major End Users
  • Figure 11: Global Gastroparesis Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Gastroparesis Drugs Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Gastroparesis Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Gastroparesis Drugs Market - TAM, US$ Billion, 2025
  • Figure 15: Global Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Gastroparesis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Gastroparesis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Gastroparesis Drugs Market, Sub-Segmentation Of Over-the-counter (OTC) Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Gastroparesis Drugs Market, Sub-Segmentation Of Prescription Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Gastroparesis Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Gastroparesis Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Gastroparesis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Gastroparesis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Gastroparesis Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Gastroparesis Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Gastroparesis Drugs Market - Company Scoring Matrix
  • Figure 98: Evoke Pharma Inc. Financial Performance
  • Figure 99: Takeda Pharmaceutical Inc. Financial Performance
  • Figure 100: AbbVie Inc. Financial Performance
  • Figure 101: Salix Pharmaceuticals Inc. Financial Performance
  • Figure 102: Pfizer Inc. Financial Performance
  • Figure 103: Global Gastroparesis Drugs Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Gastroparesis Drugs Market, Competitive Dashboard
  • Figure 105: Global Gastroparesis Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Gastroparesis Drugs Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030
  • Figure 107: Global, Gastroparesis Drugs Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Figure 108: Global, Gastroparesis Drugs Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030

Dental Sleep Medicine Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Dental Sleep Medicine Growth Trajectory: Key Forecasts and Strategic Insights

Dipeptide Peptidase 4 Inhibitors Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Dipeptide Peptidase 4 Inhibitors Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Dipeptide Peptidase 4 Inhibitors Market Landscape: Advancements In Epilepsy Treatment Solutions By Leading Pharmaceutical Companies

Read More About Emerging Trends Redefining the Dipeptide Peptidase 4 Inhibitors Market Landscape: Advancements In Epilepsy Treatment Solutions By Leading Pharmaceutical Companies

Top Trends Driving Innovation and Change in the Gastroparesis Drugs Market: Development Of Innovative Gastroparesis Treatment

Read More About Top Trends Driving Innovation and Change in the Gastroparesis Drugs Market: Development Of Innovative Gastroparesis Treatment

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Read More About Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Read More About Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Read More About Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Tactical Communication Market 2023 – By Prodcut (Networking Radios, Multiband RadioSATCOM (Satellite Communication), Video Processors, Other Products), By Platform (Underwater Tactical Communication Systems, Airborne Tac...

Metabolic Disorders Drugs Global Market Report 2022 – By Type (Anti Diabetics drugs, Anti-Thyroid Drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)), By Distribution Channel (Hospital Pharmacies, Retai...

Cardiovascular Drugs Global Market Report 2022 – By Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Dru...

Gastrointestinal Drugs Market 2022 - By Type (Antacids, Antiulcerants, Antiemetics and Antinauseants, Antidiarrheals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Root of Administrat...

Viral Vector Manufacturing Market Report 2026 - Global Outlook – By Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types), By Disease (Cancer, Genetic Disorders, I...

Gastric Cancer Drugs Market Report 2026 - Global Outlook – By Type (Imatinib, Trastuzumab, Other Types), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Clinics, Cancer Speciality Centers) - Market...

Glass Substrate Market Report 2026 - Global Outlook – By Type (Borosilicate Based, Fused Silica And Quartz Based, Other Types), By Wafer Diameter (300 mm, 200 mm, 150 mm, 125 mm, Above 300 mm, Upto 100 mm), By Applicatio...

Veterinary Orthopedic Medicine Market Report 2026 - Global Outlook – By Product (Biologics, Viscosupplements, Pharmaceuticals), By Animal Type (Canine, Feline, Equine, Cattle, Swine, Other Animal Types), By Application (...

Frequently Asked Questions

The Gastroparesis Drugs market was valued at $5.7 billion in 2025, increased to $6.02 billion in 2026, and is projected to reach $7.37 billion by 2030. request a sample here

The global Gastroparesis Drugs market is expected to grow at a CAGR of 5.2% from 2026 to 2035 to reach $7.37 billion by 2035. request a sample here

Some Key Players in the Gastroparesis Drugs market Include, Evoke Pharma Inc., Takeda Pharmaceutical Inc., AbbVie Inc., Salix Pharmaceuticals Inc., Pfizer Inc., Sanofi SA, AstraZeneca plc, Teva Pharmaceutical Inc., Bausch Health Companies Inc., Abbott request a sample here

Major trend in this market includes: Advances In Novel Therapies Aim To Improve Stomach Motility And Relieve Digestive Symptoms. For further insights on this market. request a sample here

North America was the largest region in the gastroparesis drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroparesis drugs market report are Asia-Pacific, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us